PROTOCOL IN PATIENTS (PTS) TREATED FOR PAIN IN BONE METASTASIS (MTS): IS THERE A ROLE FOR ORAL TRANSMUCOSAL FENTANYL CITRATE (OTFC)?

被引:0
作者
Daidone, A. [1 ]
Moscadini, L. [1 ]
Grillo, A. [1 ]
Mangiapane, M. [1 ]
Valentina, V. Gruppuso [1 ]
Guerrieri, P. [1 ]
Montemaggi, P. [1 ]
机构
[1] Maurizio Ascoli, Dept Radiat Oncol, Palermo, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1120
引用
收藏
页码:S378 / S378
页数:1
相关论文
共 50 条
[41]   The relationship between the around-the-clock opioid regimen and the effective dose of oral transmucosal fentanyl citrate (OTFC): A new method for dose-titration [J].
Ferraro, G. ;
Scandurra, G. ;
Rossello, R. ;
Alafaci, E. ;
Zanghi, M. ;
Montalto, E. ;
Iorfrida, M. ;
Adamo, V. .
ANNALS OF ONCOLOGY, 2006, 17 :VII157-VII157
[42]   Oral transmucosal fentanyl citrate in the outpatient management of severe cancer pain crises - A retrospective case series [J].
Burton, AW ;
Driver, LC ;
Mendoza, TR ;
Syed, G .
CLINICAL JOURNAL OF PAIN, 2004, 20 (03) :195-197
[43]   A long-term, open label study of oral transmucosal fentanyl citrate in patients with cancer [J].
Charapata, S ;
McCracken, M .
ANESTHESIOLOGY, 1997, 87 (03) :A827-A827
[44]   The relative potency of oral transmucosal fentanyl citrate compared with intravenous morphine in the treatment of moderate to severe postoperative pain [J].
Lichtor, JL ;
Sevarino, FB ;
Joshi, GP ;
Busch, MA ;
Nordbrock, E ;
Ginsberg, B .
ANESTHESIA AND ANALGESIA, 1999, 89 (03) :732-738
[45]   Oral transmucosal fentanyl citrate: Randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients [J].
Farrar, JT ;
Cleary, J ;
Rauck, R ;
Busch, M ;
Nordbrock, E .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (08) :611-616
[46]   A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial [J].
Mercadante, S. ;
Radbruch, L. ;
Davies, A. ;
Poulain, P. ;
Sitte, T. ;
Perkins, P. ;
Colberg, T. ;
Camba, M. A. .
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (11) :2805-2815
[47]   Oral trasmucosal fentanyl citrate for breakthrough pain treatment in cancer patients [J].
Mercadante, Sebastiano .
EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (06) :873-878
[48]   ORAL TRANSMUCOSAL FENTANYL CITRATE FOR PREANESTHETIC MEDICATION OF PEDIATRIC DAY SURGERY PATIENTS WITH AND WITHOUT DROPERIDOL AS A PROPHYLACTIC ANTIEMETIC [J].
FRIESEN, RH ;
LOCKHART, CH .
ANESTHESIOLOGY, 1992, 76 (01) :46-51
[49]   Pharmacokinetic and local tolerability profiles of three potential fentanyl nasal spray formulations developed for breakthrough cancer pain compared with oral transmucosal fentanyl citrate [J].
Taylor, D. R. ;
Fisher, A. N. ;
Smith, A. ;
Watling, M. ;
Knight, A. ;
Gabrail, N. Y. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[50]   Safety and Efficacy of Oral Transmucosal Fentanyl Citrate Compared to Morphine Sulphate Immediate Release Tablet in Management of Breakthrough Cancer Pain [J].
Bhatnagar, Sushma ;
Devi, Saraswathi ;
Vinod, N. K. ;
Jain, P. N. ;
Durgaprasad, G. ;
Maroo, Sanjaykumar H. ;
Patel, Ketan R. .
INDIAN JOURNAL OF PALLIATIVE CARE, 2014, 20 (03) :182-187